In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism

Hypercoagulability is frequently observed in patients with severe coronavirus disease-2019 (COVID-19). Platelets are a favorable target for effectively treating hypercoagulability in COVID-19 patients as platelet hyperactivity has also been observed. It is difficult to develop a treatment for COVID-...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yixian Quah, Yuan Yee Lee, Seung-Jin Lee, Sung Dae Kim, Man Hee Rhee, Seung-Chun Park
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-03-01
סדרה:	Journal of Ginseng Research
נושאים:	Panax ginseng hypercoagulability platelet aggregation COVID-19 molecular docking
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S1226845322001166
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!